CHARCOT MARIE TOOTH DISEASE
Clinical trials for CHARCOT MARIE TOOTH DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHARCOT MARIE TOOTH DISEASE trials appear
Sign up with your email to follow new studies for CHARCOT MARIE TOOTH DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to help CMT patients walk farther in just 3 weeks
Symptom relief CompletedThis study tested an experimental drug called NMD670 in 81 adults with Charcot-Marie-Tooth disease types 1 and 2. Participants took either the drug or a placebo twice daily for 21 days. The main goal was to see if the drug helped them walk farther in a 6-minute test, and research…
Matched conditions: CHARCOT MARIE TOOTH DISEASE
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC
-
New scale could help track CMT in kids
Knowledge-focused CompletedThis study aimed to create and test a new measurement tool called the CMT Pediatric Scale for children with Charcot-Marie-Tooth disease. Researchers enrolled 500 children under 21 with CMT to evaluate symptoms, foot and hand function, strength, sensation, balance, and motor skill…
Matched conditions: CHARCOT MARIE TOOTH DISEASE
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC